Los Angeles Capital Management LLC Mustang Bio, Inc. Transaction History

Los Angeles Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$0.73 - $1.81 $99,919 - $247,745	-136,876 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$1.66 - $2.64 $45,069 - $71,676	27,150 Added 24.74%	136,876 $227,000
Q3 2021 Nov 08, 2021	BUY	$2.58 - $3.36 $14,138 - $18,412	5,480 Added 5.26%	109,726 $295,000
Q2 2021 Aug 05, 2021	SELL	$2.7 - $3.81 $1,404 - $1,981	-520 Reduced 0.5%	104,246 $346,000
Q1 2021 May 05, 2021	BUY	$3.02 - $5.16 $37,417 - $63,932	12,390 Added 13.41%	104,766 $347,000
Q4 2020 Feb 04, 2021	SELL	$2.66 - $4.18 $10,932 - $17,179	-4,110 Reduced 4.26%	92,376 $350,000
Q3 2020 Nov 02, 2020	BUY	$3.01 - $3.88 $9,887 - $12,745	3,285 Added 3.52%	96,486 $304,000
Q2 2020 Aug 05, 2020	BUY	$2.33 - $4.6 $94,758 - $187,077	40,669 Added 77.42%	93,201 $296,000
Q1 2020 May 04, 2020	BUY	$1.91 - $4.52 $100,336 - $237,444	52,532 New	52,532 $141,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.